The management of patent ductus arteriosus in Australia and New Zealand

Journal of Paediatrics and Child Health

Volumn 45, Issue 4, 2009, Pages 204-209

  Hoellering, Adam B ^a   Cooke, Lucy ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b MATER MOTHERS HOSPITAL   (Australia)

Author keywords

Expectant therapy; Presymptomatic; Prophylaxis; Targeted prophylaxis

Indexed keywords

IBUPROFEN; INDOMETACIN;

ARTICLE; AUSTRALIA; FOLLOW UP; INFORMATION PROCESSING; INTENSIVE CARE UNIT; MEDICAL PRACTICE; NEW ZEALAND; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; QUESTIONNAIRE; SURGICAL TECHNIQUE;

AUSTRALIA; CARDIOVASCULAR AGENTS; DUCTUS ARTERIOSUS, PATENT; HUMANS; INDOMETHACIN; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE, NEONATAL; NEW ZEALAND; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES;

EID: 65349165866     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2008.01461.x     Document Type: Article

References (27)

1. Cotton R. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J. Pediatr. 1978 93 : 647 51.
2. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin. Neonatol 2001 6 : 63 73.
3. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst. Rev. 2002 3 : CD000174.
4. Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst. Rev. 2003 2 : CD003745.
5. Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst. Rev. 2007 2 : CD003480.
6. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst. Rev. 2005 4 : CD003481.
7. Schmidt B, Davis P, Modemann P et al. Long-Term effects of indomethacin prophylaxis in Extremely-Low-Birth-Weight infants. N. Engl. J. Med 2001 344 : 1966 72.
8. Evans N. Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants. Adv. Neonatal Care 2003 3 : 168 77.
9. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J. Pediatr. 2007 150 : 229 34, 234 e1.
10. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch. Dis. Child 2005 90 : F235 9.
11. Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatr. 2007 119 : 1165 74.
12. Hammerman C, Aramburo MJ. Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J. Pediatr. 1990 117 : 771 6.
13. Gersony WM, Peckham GJ, Ellison RC, Mieltinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J. Pediatr. 1983 102 : 895 906.
14. Yeh TF, Luken JA, Thalj A, Raval D, Carr I, Pildes RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus-a double-blind controlled study. J. Pediatr. 1981 98 : 137 45.
15. Van Overmerie B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P. Early versus late indomethacin for patent ductus arteriosus in premature infants with respiratory distress syndrome. J. Pediatr. 2001 138 : 205 11.
16. Ment LR, Vohr B, Allan W et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2000 105 : 485 91.
17. Schmidt B, Roberts RS, Fanaroff A et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J. Pediatr. 2006 148 : 730 4.
18. Ment LR, Stewart WB, Scott DT, Duncan CC. Beagle puppy model of intraventricular haemorrhage; randomized indomethacin prevention trial. Neurology 1983 33 : 179 84.
19. Kluckow M, Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch. Dis. Child 2000 82 : F188 94.
20. Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990 21 : 777 84.
21. Ohlsson A, Bottu J, Govan J, Ryan ML, Fong K, Myhr T. The effect of indomethacin on cerebral blood flow velocities in very-low-birth-weight neonates with patent ductus arteriosus. Dev. Pharmacol. Ther. 1993 20 : 100 6.
22. Doyle LW. Outcome at 5 years of age of children 23 to 27 weeks' gestation: refining the prognosis. Pediatrics 2001 108 : 134 41.
23. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol. Neonate 2006 89 : 330 5.
24. Laughon MM, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr. Opin. Pediatr. 2004 16 : 146 51.
25. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am. J. Perinatol. 2001 18 : 1 7.
26. Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J. Pediatr. 1996 128 : 601 97.
27. Clyman RI, Mauray F, Roman C et al. Effects of antenatal glucocorticoid administration on ductus arteriosus in preterm lambs. Am. J. Physiol. 1981 241 : H425 20.